Alan Talevi

Publication Activity (10 Years)

Years Active: 2007-2023
Publications (10 Years): 10

Top Topics

Strengths And Weaknesses

Quasi Invariant

Virtual Screening

Top Venues

J. Chem. Inf. Model.

J. Comput. Aided Mol. Des.

Publications

Manuel A. Llanos, Nicolas Enrique, Vega Esteban-López, Sebastian Scioli-Montoto, David Sánchez-Benito, María E. Ruiz, Veronica Milesi, Dolores E. López, Alan Talevi, Pedro Martín, Luciana Gavernet
A Combined Ligand- and Structure-Based Virtual Screening To Identify Novel NaV1.2 Blockers: In Vitro Patch Clamp Validation and In Vivo Anticonvulsant Activity. J. Chem. Inf. Model. 63 (22) (2023)
Manuel A. Llanos, Lucas N. Alberca, María D. Ruiz, María L. Sbaraglini, Cristian Miranda, Agustina Pino-Martinez, Laura Fraccaroli, Carolina Carrillo, Catalina D. Alba Soto, Luciana Gavernet, Alan Talevi
A combined ligand and target-based virtual screening strategy to repurpose drugs as putrescine uptake inhibitors with trypanocidal activity. J. Comput. Aided Mol. Des. 37 (2) (2023)
Melisa E. Gantner, Denis N. Prada Gori, Manuel A. Llanos, Alan Talevi, Andrea Angeli, Daniela Vullo, Claudiu T. Supuran, Luciana Gavernet
Identification of New Carbonic Anhydrase VII Inhibitors by Structure-Based Virtual Screening. J. Chem. Inf. Model. 62 (19) (2022)
Denis N. Prada Gori, Manuel A. Llanos, Carolina L. Bellera, Alan Talevi, Lucas N. Alberca
iRaPCA and SOMoC: Development and Validation of Web Applications for New Approaches for the Clustering of Small Molecules. J. Chem. Inf. Model. 62 (12) (2022)
Jorge Enrique Hernández González, Lucas N. Alberca, Yordanka Masforrol González, Osvaldo Reyes Acosta, Alan Talevi, Emir Salas-Sarduy
Tetracycline Derivatives Inhibit Plasmodial Cysteine Protease Falcipain-2 through Binding to a Distal Allosteric Site. J. Chem. Inf. Model. 62 (1) (2022)
Manuel A. Llanos, Nicolas Enrique, María L. Sbaraglini, Federico M. Garofalo, Alan Talevi, Luciana Gavernet, Pedro Martín
. J. Chem. Inf. Model. 62 (12) (2022)
Manuel A. Llanos, Melisa E. Gantner, Santiago Rodriguez, Lucas N. Alberca, Carolina L. Bellera, Alan Talevi, Luciana Gavernet
Strengths and Weaknesses of Docking Simulations in the SARS-CoV-2 Era: the Main Protease (Mpro) Case Study. J. Chem. Inf. Model. 61 (8) (2021)
Julián A. Bélgamo, Lucas N. Alberca, Jorge L. Pórfido, Franco N. Caram Romero, Santiago Rodriguez, Alan Talevi, Betina Córsico, Gisela R. Franchini
Application of target repositioning and in silico screening to exploit fatty acid binding proteins (FABPs) from Echinococcus multilocularis as possible drug targets. J. Comput. Aided Mol. Des. 34 (12) (2020)
Melisa E. Gantner, Roxana N. Peroni, Juan F. Morales, María L. Villalba, María E. Ruiz, Alan Talevi
Development and Validation of a Computational Model Ensemble for the Early Detection of BCRP/ABCG2 Substrates during the Drug Design Stage. J. Chem. Inf. Model. 57 (8) (2017)
Lucas N. Alberca, María L. Sbaraglini, Darío E. Balcazar, Laura Fraccaroli, Carolina Carrillo, Andrea Medeiros, Diego Benitez, Marcelo Comini, Alan Talevi
Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning. J. Comput. Aided Mol. Des. 30 (4) (2016)
Carolina L. Bellera, Darío E. Balcazar, Lucas N. Alberca, Carlos A. Labriola, Alan Talevi, Carolina Carrillo
Application of Computer-Aided Drug Repurposing in the Search of New Cruzipain Inhibitors: Discovery of Amiodarone and Bromocriptine Inhibitory Effects. J. Chem. Inf. Model. 53 (9) (2013)
Mauricio E. Di Ianni, Andrea V. Enrique, Pablo H. Palestro, Luciana Gavernet, Alan Talevi, Luis Bruno Blanch
Several New Diverse Anticonvulsant Agents Discovered in a Virtual Screening Campaign Aimed at Novel Antiepileptic Drugs to Treat Refractory Epilepsy. J. Chem. Inf. Model. 52 (12) (2012)
Alan Talevi, Carolina L. Bellera, Eduardo A. Castro, Luis Bruno Blanch
A successful virtual screening application: prediction of anticonvulsant activity in MES test of widely used pharmaceutical and food preservatives methylparaben and propylparaben. J. Comput. Aided Mol. Des. 21 (9) (2007)